Structure-activity relationships for benzotriazine di-N-oxides

Area of Science:

• Biomedical research
• Pharmacology
• Medicinal chemistry

Background:

• SR 4233 (3-amino-1,2,4-benzotriazine 1,4-dioxide) is a bioreductive agent effective against hypoxic mammalian cells and murine tumors.
• Understanding its mechanism and exploring superior analogs is crucial for developing improved cancer therapies.

Purpose of the Study:

• To evaluate 15 benzotriazine-di-N-oxide analogs of SR 4233.
• To correlate physicochemical properties with biological activity (hypoxic/aerobic toxicity, oxygen consumption, in vivo toxicity).
• To identify potential superior analogs for cancer treatment.

Main Methods:

• In vitro assessment of hypoxic and aerobic cytotoxicity in CHO cells.
• Measurement of drug-induced oxygen consumption in respiration-inhibited cells.
• Determination of acute LD50 in BALB/c mice.
• Correlation analysis with polarographic half-wave reduction potential (E1/2).

Main Results:

• Hypoxic cytotoxicity and oxygen consumption stimulation positively correlated with E1/2 (electron affinity).
• Maximum air-to-nitrogen differential cytotoxicity observed at SR 4233's E1/2, decreasing with higher E1/2.
• Acute mouse LD50 decreased as E1/2 increased.
• SR 4482 demonstrated higher in vitro hypoxic cell toxicity and lower mouse toxicity than SR 4233.

Conclusions:

• Physicochemical properties, particularly E1/2, significantly influence the biological activity of benzotriazine-di-N-oxide analogs.
• SR 4482 represents a promising new analog with a potentially improved therapeutic index.
• This study suggests a new subseries of 1,2,4-benzotriazines with distinct structure-activity relationships.